Skip to main content
OpenTrials

Clinical trial condition

Pancreatic Cancer

Explore clinical trials studying Pancreatic Cancer. Study availability and eligibility vary by location and protocol.

1,289 public trials 285 recruiting studies
Refine in advanced search Browse all conditions

Pancreatic Cancer trial results

Recruiting

Integrated Cancer Repository for Cancer Research

NCT02012699

Conditions
Abdominal Neoplasms, Adenoma, Adenomatous Polyposis Coli, +195 more
Locations
  • Advent Health Greenwood Village, Colorado, United States
  • Hartford HealthCare Cancer Institute at Manchester Medical Hospital Manchester, Connecticut, United States
  • Florida Hospital Memorial Medical Center Daytona Beach, Florida, United States
  • Florida Hospital DeLand DeLand, Florida, United States
View all 42 locations
View Trial Details
Recruiting

A Study of ELI-002 7P, With or Without Tislelizumab, in People With Pancreatic Cancer

NCT07671339

Conditions
Digestive System Diseases, Digestive System Neoplasms, Endocrine Gland Neoplasms, +6 more
Locations
  • Memorial Sloan Kettering at Basking Ridge (Limited Protocol Activities) Basking Ridge, New Jersey, United States
  • Memorial Sloan Kettering Monmouth (Limited Protocol Activities) Middletown, New Jersey, United States
  • Memorial Sloan Kettering Bergen (Limited Protocol Activities) Montvale, New Jersey, United States
  • Memorial Sloan Kettering Suffolk-Commack (Limited Protocol Activities) Commack, New York, United States
View Trial Details
Recruiting

Pancreatic Cancer Screening Using the Enzeavour Assay in Japan

NCT07605819

Conditions
Digestive System Diseases, Digestive System Neoplasms, Endocrine Gland Neoplasms, +6 more
Locations
  • Aichi Medical University Hospital Nagakute, Aichi-ken, Japan
  • Nagoya University Hospital Nagoya, Aichi-ken, Japan
  • Hiroshima University Hospital Hiroshima, Japan
  • JA Onomichi General Hospital Onomichi, Hiroshima, Japan
View all 48 locations
View Trial Details
Recruiting

Study to Assess Adverse Events and Pharmacokinetics in Adult Participants With Non-Small Cell Lung Cancer, Head and Neck Squamous Cell Carcinoma and Other Solid Tumors, Receiving Intravenous Infusion of Azirkitug Alone or in Combination(s) With Budigalimab, Bevacizumab, or Telisotuzumab Adizutecan

NCT05005403

Conditions
Anophthalmia with pulmonary hypoplasia, Breast Diseases, Breast Neoplasms, +38 more
Locations
  • City of Hope National Medical Center /ID# 276272 Duarte, California, United States
  • City of Hope - Orange County Lennar Foundation Cancer Center /ID# 278589 Irvine, California, United States
  • USC Norris Comprehensive Cancer Center /ID# 279603 Los Angeles, California, United States
  • University of Illinois Hospital and Health Sciences System /ID# 251750 Chicago, Illinois, United States
View all 48 locations
View Trial Details
Recruiting

A Pan-European Post-Authorisation Safety Study: Risk of Pancreatic Cancer Among Type 2 Diabetes Patients Who Initiated Exenatide as Compared With Those Who Initiated Other Non-Glucagon-Like Peptide 1 Receptor Agonists Based Glucose Lowering Drugs

NCT05663515

Conditions
Digestive System Diseases, Digestive System Neoplasms, Endocrine Gland Neoplasms, +6 more
Locations
  • Research Site Copenhagen, Denmark
  • Research Site Helsinki, Finland
  • Research Site Paris, France
  • Research Site Bergen, Norway
View Trial Details
Recruiting

A Trial of RSC-1255 for Treatment of Patients With Advanced Malignancies

NCT04678648

Conditions
Advanced Malignant Solid Neoplasm, Astrocytoma, Colon Cancer, +35 more
Locations
  • University of California, Los Angeles (UCLA) Department of Medicine - Hematology/Oncology Los Angeles, California, United States
  • Sarah Cannon, SCRI Oncology Partners - Health One Denver, Colorado, United States
  • Sarah Cannon, SCRI Oncology Partners Nashville, Tennessee, United States
View Trial Details

Related conditions